1. Review the epidemiology and clinical features of psoriatic arthritis.
2. Identify radiographic features of psoriatic arthritis.
3. Describe treatment strategies for the various manifestations of psoriatic arthritis.
Journal Review article:
Efficacy and Safety of Guselkumab, an Interleukin‐23p19–Specific Monoclonal Antibody, Through One Year in Biologic‐Naive Patients With Psoriatic Arthritis
Arthritis & Rheumatology, Vol 73, Issue 4, pp..604-616
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation